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Abstract
Background: Hepatitis C virus (HCV) infection is a growing problem among people who inject drugs. Strategies to reduce
disease transmission (eg, syringe exchange programs) and facilitate HCV screening and linkage are available but are under-utilized
in many communities affected by injection drug use. Novel approaches to increasing the use of these strategies are needed.
Objective: The goals of this project are to (1) develop and pilot test a computerized tailored intervention for increasing HCV
screening and decreasing risky drug use behavior among people who inject drugs and (2) determine the feasibility of disseminating
such an intervention using peer-based referrals in the setting of a community-based syringe exchange program.
Methods: This 2-arm, randomized pilot study is being conducted in a large-volume, multisite syringe exchange program in
southern Wisconsin. A social network–based strategy was used to recruit a total of 235 adults who reported past-month injection
of opioids, cocaine, or methamphetamine. Network recruiters were identified among clients requesting services from the syringe
exchange program and were enlisted to refer eligible peers to the study. All participants completed a computer-adapted questionnaire
eliciting information about risk behaviors and their knowledge, attitudes, and prior experiences related to HCV screening. Subjects
were then randomly assigned to receive usual care, consisting of standard counseling by syringe exchange staff, or the Hep-Net
intervention, which provides algorithm-based, real-time tailored feedback and recommendations for behavior change in the style
of motivational interviewing. Changes in drug use behaviors and attitudes will be assessed during a second session between 90
and 180 days after the baseline visit. Frequency of repeat HCV testing and HCV incidence will be assessed through a database
search 1 year after study completion.
Results: Recruitment for this study was completed in April 2015. Follow-up of enrolled participants is expected to continue
until March 2016. Network recruiters were enrolled who referred a total of 195 eligible peers (overall N=235). At baseline, the
median age was 34 years; 41.3% (97/235) were non-white; and 86.4% (203/235) reported predominantly injecting heroin. Most
participants (161/234, 68.8%) reported sharing injection equipment in the past and of these, 30.4% (49/161) had never been tested
for HCV.
Conclusions: This study will provide preliminary evidence to determine whether incorporating computerized behavioral
interventions into existing prevention services at syringe exchange programs can lead to adoption of healthier behaviors.
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Introduction
Objectives
The overall goal of this project is to explore whether deploying
a computer-adapted behavioral intervention coupled with onsite,
rapid hepatitis C virus (HCV) screening is a feasible and
acceptable approach to reducing transmission risk behavior and
improving HCV case detection in the setting of a syringe
exchange program. The intervention described in this paper
incorporates lessons from formative research conducted with
the target population [1] and prior experience implementing
social network strategies for HIV testing within
community-based prevention agencies [2]. In this manuscript,
we describe the development of the Hep-Net intervention and
its implementation and evaluation through a pilot randomized
controlled trial (RCT). We present baseline data describing the
participants enrolled and discuss challenges encountered
disseminating the intervention using peer-based referrals.
Background
Epidemiologic studies suggest that HCV transmission is
increasingly driven by injection drug use among young adults
in rural and suburban settings. A cluster investigation in 6
contiguous rural counties in northern Wisconsin found that the
number of HCV infections reported annually increased by more
than 200% between the periods 2004-2008 and 2009-2010 [3].
Among individuals newly diagnosed with HCV in this outbreak,
94% reported a history of sharing needles or other drug
preparation equipment. In this investigation and in similar
outbreaks in Massachusetts [4], rural Indiana [5], and several
Appalachian states [6], many young adults described a history
of injecting prescription opioid medications for several years
before transitioning to injecting heroin or methamphetamine.
These sharp increases in HCV incidence concentrated in
communities with traditionally poor access to prevention
services highlight the need for evidence-based, targeted
interventions to reduce HCV transmission and coordinate efforts
to increase HCV testing and linkage to treatment for those who
are infected [7].
Syringe exchange programs are a widely used strategy to reduce
harm related to injection drug use. Numerous observational
studies support the effectiveness of syringe programs for
reducing behaviors leading to transmission of HIV and viral
hepatitis and increasing entry into drug treatment programs
[8-11]. Ensuring the availability of sterile syringes and other
drug injection equipment, while a necessary component of
disease prevention for people who inject drugs, is only one of
several strategies that can be implemented through syringe
exchange programs [12,13]. Other important components of
risk reduction include linkage to addiction treatment, overdose
prevention, and testing and linkage to care for HIV, viral
hepatitis, and sexually transmitted infections. However, resource
limitations pose challenges to consistently delivering
multicomponent services that meet the diverse needs of people
who inject drugs. Syringe exchange programs face resource
limitations that are driven by social and political factors such
as prohibitions on federal funding and local opposition. Many
syringe exchange programs have insufficient resources to
provide adequate syringe coverage or deliver a full package of
preventative services to their clients [14]. Further, even when
prevention services are available in the community and are of
no cost to clients, many high-risk individuals still cannot or do
not access syringe exchange programs due to myriad
environmental and psychosocial barriers. As a result, many
people who inject drugs are not regularly engaged in prevention
services [15].
Novel Approaches
Computerized Interventions
Computer-based interventions deployed in syringe exchange
programs or other community-based settings may represent a
promising, low-cost strategy for delivering tailored health
information that is specific to the needs of people who inject
drugs. Studies examining computer-tailored interventions (CTIs)
have shown positive behavior changes in a wide range of
contexts, including alcohol reduction in college students,
preconception care in women, and HIV prevention among
juvenile offenders and drug users [16-19]. A meta-analysis of
88 CTIs showed a significant effect size for behavior change
in smoking cessation, mammography, physical activity, and
dietary practices, indicating CTIs have a clinically significant
impact on rates of behavioral risk factors [20].
CTIs assess individual behavior, environmental barriers, and
psychosocial determinants of positive behavior change. They
then use data-driven decision guidelines to construct automatic,
tailored feedback providing each individual with a personalized
approach to risk reduction. CTIs are mobile, user-friendly, and
brief. As such, CTIs may have an advantage in engaging
transient, hard-to-reach populations in resource-constrained
prevention settings such as syringe exchange programs.
Extending Prevention Services Through Social Networks
Strategies to increase engagement in prevention services must
address environmental barriers such as geographic
inaccessibility and psychosocial barriers related to individual
motivation and behavioral skills. Social network-based
strategies, which have been developed and implemented in
many US cities to increase HIV testing, may facilitate
dissemination of prevention services through both of these
domains. In a demonstration project funded by the Centers for
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Disease Control and Prevention (US Department of Health and
Human Services) conducted in 7 US cities, 5.6% of clients
recruited through peer referrals were HIV positive compared
to a prevalence of approximately 1% who self-referred [21-23].
Programs to promote HIV testing have taken advantage of
existing social networks and the meaningful influence of peers
by enlisting high-risk clients to recruit, refer, or otherwise
encourage their associates to participate in testing. Adaptation
of this strategy to deliver HCV testing and prevention services
to people who inject drugs was one of the factors motivating
the development of this project.
Methods
Study Design
The Hep-Net Intervention: Overall Objectives
This project has two main objectives. First, it aims to determine
whether a CTI is a feasible and acceptable approach to
increasing readiness to engage in various health-promoting
behaviors among people who inject drugs. It targets 4 different
behavioral domains: (1) undergoing regular HCV screening,
(2) using clean works for every injection, (3) taking steps to
prevent opioid overdose, and (4) reducing and ultimately ceasing
injection drug use. The second objective is to determine the
feasibility of using social networks to expand delivery of
computerized prevention interventions to hard-to-reach people
who inject drugs.
Theoretical Frameworks
Hep-Net is grounded in behavior change theory and motivational
interviewing techniques. The guiding behavioral theory is the
integrative model of behavior change, which is schematized in
Figure 1 [24,25]. The integrative model and its historical
predecessors, the theory of planned behavior [26] and the theory
of reasoned action [27], are supported by evidence across a wide
array of health behaviors and populations [28-31]. The
integrative model expands the scope of the theory of planned
behavior and the theory of reasoned action by acknowledging
the importance of skills, abilities, and environmental constraints
as moderators of the relationship between behavioral intention
and action [32].
Hep-Net is also guided by the transtheoretical model (ie, stages
of change), which assumes that behavior change should be
considered a continuum rather than a dichotomy [33,34].
Specifically, behavior change occurs through a series of stages
in which individuals can move back and forth. In the
precontemplation stage, individuals are not yet considering
behavior change. In the contemplation stage, individuals may
be considering change but have not yet taken steps toward
behavioral change. Contemplation is followed by preparation,
action, and maintenance. Although the stages are considered
serial, one may skip particular stages (eg, planning/preparation)
and, at any point in the continuum, one may digress to a previous
stage of readiness (ie, from action to preparation). The Hep-Net
system uses motivational interviewing techniques, which are
founded on the transtheoretical model, to assess readiness for
change with respect to safe injection practices, substance use
reduction, and overdose prevention. The model also informed
the types of specific feedback and risk reduction activities
suggested to participants, as described below in the discussion
of the risk reduction exercise.
Figure 1. The Integrative Model (adapted from Fishbein [24]).
Formative Research and Intervention Development
Using the integrative and transtheoretical models as the guiding
frameworks, the system assesses participants’ risks and
protective behaviors; preferences for behavior change domain
(eg, decreasing risky injection practices, reducing opioid use,
overdose prevention); and attitudinal, normative, and efficacy
beliefs. The system then tailors the content of the intervention
to the individuals’ stage of readiness for change, salient beliefs,
and the chosen behavioral target (eg, safer injection practices).
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To develop appropriate questionnaire items and
health-promotion messages that address relevant beliefs held
by the target population, we analyzed formative data collected
through an anonymous cross-sectional survey of 553 syringe
exchange clients [1]. Health promotion messages specifically
tailored to individual stages of readiness to change were
developed collaboratively by a research team of investigators
with expertise in health communications, counseling
psychology, and clinical medicine. Draft messages were
discussed at in-person meetings and later pilot tested with
several end-users who were current or previous clients of the
syringe exchange program to elicit feedback to inform further
refinement of messages.
The risk assessment survey and tailored behavioral computerized
intervention were delivered using an Internet-based,
customizable, interactive software tool developed in consultation
with DatStat Inc (Seattle, WA). DatStat performed all necessary
programming for creation of the intervention. The tool provided
a patient-driven counseling experience similar to those used in
other studies of high-risk populations [35,36]. The intervention
simulated a motivational interview, asking contextually
appropriate questions, and was intended to capture the essence
of a patient clinical experience on a computer. In real time, the
program synthesized patient responses about risks, knowledge,
and beliefs; presented a list of risk factors to the participant
based on those responses; and then guided the participant in
developing an individualized risk reduction plan.
After developing and pilot testing the intervention with a small
number of volunteers, we proceeded to recruitment and
enrollment in the pilot RCT. The study protocol was reviewed
and approved as a minimal risk study by the Health Sciences
Institutional Review Board at the University of
Wisconsin-Madison.
Study Population, Recruitment, Eligibility, and
Screening
Enrollment in the study began in September 2014, and all
baseline assessments were completed by April 2015. Participants
in the study were either clients of an established, multisite
syringe exchange program operating in southern Wisconsin or
peers recruited from the social networks of these clients.
Eligibility criteria included age 18 years or older, injection drug
use in the past 30 days, and willingness to provide contact
information for the 3-month follow-up. Pregnant women and
people who did not speak English were excluded. As one goal
of the study is to conduct outreach among high-risk populations
who do not regularly use prevention services, we used social
network–based referrals to recruit the majority of the study
sample. Syringe exchange clients were informed about the study
and screened for eligibility during a routine encounter at the
syringe exchange program. Upon completion of the baseline
visit, study participants received referral coupons and were
encouraged to refer eligible peers. Coupons were marked with
a unique code number used to track referral chains. Participants
received US $10 in cash as compensation for time spent
completing the baseline study encounter and an additional US
$10 for each eligible peer they referred (up to 5) who enrolled
in the study.
Baseline Study Assessment
At the initial study encounter, participants were encouraged to
get a rapid HCV antibody test unless they had had a positive
HCV antibody test in the past or had gotten a rapid HCV test
within the last 3 months. Receiving an HCV test was not a
requirement for participation in the study; it is a standard service
offered to all syringe exchange clients. The computerized survey
was designed to last 20 to 30 minutes. For those consenting to
HCV testing, the baseline assessment was administered after
participants provided a fingerstick blood specimen for the rapid
HCV test, allowing them time to complete most of the baseline
assessment while awaiting the test results. The complete baseline
questionnaire is reproduced in Multimedia Appendix 1.
Question items were developed based on the integrative model
to evaluate attitudes, norms, and self-efficacy beliefs relevant
to each of the targeted health behaviors. Table 1 displays sample
question items assessing the relevant constructs in the integrative
model for the behavior of HCV testing. Response options to
each of these questions were a 5-point Likert scale ranging from
“strongly disagree” to “strongly agree.” Participants rated their
readiness to make changes toward each of 4 behavioral goals:
(1) “I will cut down on my drug use or quit using drugs
completely,” (2) “I will use clean needles, cottons, and cookers
every time I inject drugs,” (3) “I will get tested for hepatitis C
every 6 months for as long as I’m using,” and (4) “I will get
trained to give naloxone (or Narcan) in case someone I am with
has an overdose.”
Table 1. Examples of questions based on the integrative model.
Integrated model domainSurvey question
Self-efficacy“I am confident that if I really wanted to, I could get tested for hepatitis C every six months,
for as long as I am shooting drugs.”
Injunctive normative beliefs“Most people who are important to me think I should get tested for hepatitis C.”
Descriptive normative beliefs“Most people who are similar to me have been tested for hepatitis C.”
Attitudes“Getting tested for hepatitis C is important to me.”
Using the transtheoretical model, we assessed readiness to adopt
specific healthy behaviors using the visual analog scale shown
in Figure 2. Each behavior was characterized as a health-related
goal that a person who injects drugs may have, and respondents
were asked to characterize their readiness to adopt the behavior
by selecting a statement on the spectrum of “I am not even
thinking about this goal” (precontemplation stage) to “I have
reached this goal” (maintenance stage). For the intervention
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group, the stage of change reported by respondents during the
baseline session was used in the algorithms to determine what
tailored content would be displayed in the subsequent risk
reduction intervention.
The baseline questionnaire included basic demographic and
locator information, including multiple means of electronic
communication (eg, text messaging, email, Facebook) to
facilitate coordination of follow-up. Additional sections included
a risk behavior questionnaire assessing addiction severity,
overdose risk, and injection-related and sexual behaviors
associated with transmission of HCV. To maximize accurate
disclosure of high-risk and sensitive behaviors, both the baseline
questionnaire and the tailored intervention used audio
computer-assisted self-interview. As an enhancement designed
to better simulate a motivational interviewing session,
photographs of a model portraying a counselor were embedded
in the survey program to accompany the audio-recorded
instructions, survey questions, and, if applicable, tailored
feedback messages. At the beginning of the session, participants
selected 1 of 3 female avatars that appeared to have varying
racial/ethnic backgrounds. The avatar selected by the participant
would be displayed throughout the baseline session and the
subsequent follow-up assessment 3 months later.
Figure 2. Assessment of readiness to change based on the Transtheoretical Model.
Randomization
After completion of all required sections of the baseline survey,
participants were randomly assigned to receive the risk reduction
intervention or be in the control group, in which the computer
session terminated after completion of the survey. Both the
intervention and control groups received individualized
prevention counseling per standard of care at the syringe
exchange programs. Challenges related to data synchronization
across multiple sites and the need for offline data collection in
rural communities made stratified, block randomization
infeasible. Therefore, simple randomization was used to place
participants to either group using the survey software during
the baseline session.
Intervention Content
Overview
Participants assigned to receive the risk reduction intervention
were presented with a series of screens featuring text and audio
content summarizing the participant’s risk behaviors and
delivering health-promotion messages. Components of the
tailored intervention consisted of an overall risk synthesis,
selection of behavioral goal, and individualized risk reduction
exercise and assessment of self-efficacy related to risk reduction
plan. An example of the series of content screens displayed for
a participant in the precontemplation stage with respect to
overdose prevention is reproduced in Multimedia Appendix 2.
Risk Synthesis
The risk synthesis was introduced with 1 screen displaying
positively framed feedback messages emphasizing behaviors
reported by the participant that can reduce risk of HCV
transmission and/or opioid overdose. A subsequent screen
displayed tailored feedback regarding specific behaviors
associated with increased risk reported by the participant.
Selection of Behavioral Goal
In the second portion of the intervention, participants chose a
behavioral goal they would like to work on over the next 3
months (HCV testing, Narcan training, use of clean needles or
works, or reducing or suspending drug use) and selected action
steps tailored to the participants’assessed stage of change within
that one risk category. The relevant stage of change was
determined by responses to questions addressing the risk
reduction goals.
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After selecting a behavioral risk reduction goal, participants
received a message introducing the activity that was tailored to
their self-reported stage of readiness to change, relevant to that
particular risk category. Participants were then guided through
a series of screens which gave feedback and educational content
(eg, the opportunity to view a brief video) tailored to the types
of risk behaviors and stage of readiness to change. Messages
were designed to encourage movement along the stages of
change in the direction of action/maintenance.
Individualized Risk Reduction Exercise
The final intervention component was an interactive activity in
which participants were asked to create a risk reduction plan.
Participants were presented with a list of 10 to 12 possible
suggested action steps related to the risk reduction goal they
selected. The content of these lists was informed by the
transtheoretical model, encouraging incremental change through
concrete actions that could be taken. Participants were asked to
select 3 to 5 of the steps they felt they would be able to do in
the ensuing 3 months. After participants selected the steps, their
individualized risk reduction plan was read back to them. They
were asked to confirm their selected steps and given an
opportunity to go back and change their choices. Finally,
participants were asked to answer a series of questions assessing
confidence in their ability to complete their plan.
Follow-Up Assessments and Outcome Measures
Upon completion of the baseline session, participants were
reminded of the need to return for a follow-up assessment 3
months after the baseline session. The second study visit uses
an Internet-based survey designed to assess the same behavioral
and attitudinal domains captured through the baseline
questionnaire. This allows us to evaluate any temporal changes
in the frequency of substance use, injection risk behaviors,
overdose risk, and HCV testing. The follow-up assessment also
evaluates self-reported readiness to change, attitudes, and
perceived norms, providing an opportunity to detect whether
the tailored intervention may influence outcomes through these
intermediate variables.
In addition to repeating the assessment of baseline variables for
longitudinal analysis, the follow-up questionnaire captures
information on participant perceptions about whether they met
any of the health goals discussed in the baseline session. For
participants determined to be HCV-infected at baseline, the
survey assesses whether they received any follow-up testing or
medical care for HCV since receiving their test result. Finally,
it evaluates usability and acceptability of the intervention
through a series of questions delivered to participants who were
randomized to the active study arm. The additional questionnaire
items used during the follow-up assessment are presented in
Multimedia Appendix 3.
There are multiple behavioral outcomes of interest in this
project. Accurate assessment of drug use behaviors may be
limited because it relies on participant self-report and may be
biased due to losses to follow-up. HCV testing behavior may
be captured with greater validity because it will be ascertained
by searching HCV testing data collected and reported by all
agencies receiving funding from the Wisconsin Division of
Public Health. For participants who have received a reactive
HCV screening test result, we will determine whether any
follow-up testing was performed, including confirmatory HCV
RNA or HCV genotype tests, which would indicated that the
participant was linked to evaluation and/or treatment of HCV.
Sample Size and Power
Demonstrating efficacy of the intervention through detection
of a statistically significant effect size was not a primary goal
of the project. However, we considered it plausible that the
intervention might significantly influence participants’decisions
to receive HCV testing even after a single session. While
planning the pilot trial, we calculated a target sample size that
would be sufficient to detect what we considered to be a
meaningful difference in the proportion of participants who
undergo HCV testing within 12 months after enrollment.
Assuming that approximately 10% of participants would be
known to have HCV infection at enrollment and accounting for
expected losses to follow-up, we estimated that a sample size
of 408 would provide 90% power to detect a difference of 0.15
in the proportion of participants who voluntarily returned for
an HCV test within a year of enrollment.
We believed that achieving a target sample size of 408 was
feasible and justified based on data from the pilot survey
conducted in 2012 reporting that 69.4% of syringe exchange
clients had an HCV test in the prior 12 months and 14.9% of
clients had ever had a positive HCV test [1]. Because this
intervention was targeting people who inject drugs but may not
be regular users of the syringe exchange program, we anticipated
that the number reporting prior HCV testing would be lower.
We believed an effect size of this magnitude was reasonable
based on prior meta-analyses of tailored communication
interventions, which provide support for moderate mean
intervention effect sizes [20] across a variety of health behaviors,
including addiction-related behaviors (eg, smoking) and HIV
risk-related behaviors [37]. Notably, findings suggested effect
sizes increased with the number of behaviors intervened upon,
with mean effect size of g=.24 (95% CI 0.18-0.31) for
interventions focused on 3 behaviors [20].
Data Analysis
Descriptive statistics reported here were calculated for baseline
variables using SAS 9.3 (SAS Institute Inc). Differences in
participant characteristics were assessed using a Wilcoxon
rank-based general linear model approach for continuous
variables and Pearson chi-square or Fisher exact tests for
differences in categorical variables.
To evaluate the effectiveness of the risk reduction intervention,
we will test within-group changes from baseline to follow-up
(eg, change in frequency of needle-sharing) using the
matched-pair Wilcoxon rank-sum test. Similarly, binary outcome
changes will be examined using either the McNemar test or
Fisher exact test.
To assess the independent role of the intervention in improving
screening for HCV, we will use a logistic regression model on
the binary outcome of having an HCV test within the 12-month
period postintervention. Again, a Wilcoxon general linear model
framework will be used for analysis of Likert scale outcome
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measures. Indicators pertaining to individual level outcomes
within intervention and control groups will be measured among
the same individuals at baseline and follow-up.
To avoid potential sampling bias toward individuals with larger
networks, we will adjust regression models using inverse
probability weights based on individual recruitment network
sizes [33]. To account for correlation between recruiter and
recruited, we will create a variable indicating who the recruiter
of each subject was and use it as a cluster variable using
generalized estimating equations. An exchangeable correlation
structure within each cluster will be assumed (ie, correlation
between any 2 subjects recruited by the same recruiter will be
assumed to be the same). For all tests, a 2-sided P value of less
than .05 is considered statistically significant.
Results
Between September 2014 and April 2015, 235 people completed
the baseline survey. Baseline descriptive characteristics of the
sample are displayed in Table 2. The racial/ethnic breakdown
was reflective of the general population of the region, with
non-Hispanic whites comprising 60.3% (129/232) of the sample
and those self-described as black or African American
comprising 28.1% (66/235). The median age was 35 years (range
18-63 years). While most participants who provided a valid
address (131/219, 59.8%) lived in the city of Milwaukee, about
one-third (70/219, 29.0%) of participants resided in a
municipality with a population less than 50,000 residents,
including 17.8% (39/219) who lived in a city with a population
less than 5,000. Comparison of the control and intervention
groups with respect to baseline characteristics demonstrated no
statistically significant differences, assuming a 2-sided alpha
of .05.
Table 2. Baseline characteristics by intervention group (N=235).
Intervention
(N=109)
Control
(N=126)
CategoryCharacteristics
33 (27-44)35 (28-46)Age, years, median (IQR)
89 (81.7)92 (73.0)MaleGender, n (%)
20 (18.3)34 (27.0)Female
59 (54.1)79 (63.0)WhiteRace, n (%)
34 (31.2)32 (25.0)Black
16 (14.7)15 (12.0)Other or multiple
102 (94.4)112 (90.3)Non-Hispanic/LatinoEthnicity, n (%)
6 (5.6)12 (9.7)Hispanic/Latino
7 (6.4)17 (13.5)Less than high schoolHighest education level, n (%)
51 (46.8)61 (48.4)HS diploma or GED
47 (43.1)45 (35.7)Some college or vocational school
4 (3.7)3 (2.4)College degree
69 (64.0)92 (73.0)NoCurrently employed, n (%)
39 (36.0)34 (27.0)Yes
30 (27.5)31 (26.0)NoneLegal income in last year, n (%)
49 (45.0)62 (51.0)US $1-11,500
30 (27.5)28 (23.0)More than US $11,500
52 (48.0)58 (46.0)NoHomeless during the past year, n (%)
56 (52.0)68 (54.0)Yes
63 (59.0)82 (66.0)NoIncarcerated during the past year, n (%)
44 (41.0)42 (34.0)Yes
11 (10.0)20 (16.0)NoHas health insurance, n (%)
98 (90.0)105 (84.0)Yes
39 (36.0)53 (42.4)NoHas primary care provider, n (%)
69 (64.0)72 (57.6)Yes
Of the 235 participants who completed the baseline assessment,
80 (34.0%) agreed to receive a rapid HCV test, and 14 (17.5%)
tests were reactive. The most common reasons given for
declining the test were the participant had been previously tested
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(36/155, 23.2%), did not want to or did not feel ready to be
tested (22/155, 14.2%), already knew he or she was
HCV-positive (17/155, 11.0%), and did not have enough time
(13/155, 8.0%).
Drug use characteristics of the baseline sample are displayed
in Table 3. Heroin was the drug most frequently injected by
participants and nearly half (105/235, 44.7%) reported that they
inject on a daily basis. Most participants (161/234, 68.8%)
reported they had shared syringes, cotton filters, or cookers with
other people while injecting drugs in the past. Of those reporting
sharing injection equipment in the past, 44.1% (71/161) had
shared syringes, cottons, or cookers during the past 3 months,
and 30.4% (49/161) reported they had never been tested for
HCV.
Table 3. Drug use characteristics by intervention group (N=235).
Intervention
(N=109)
n (%)
Control
(N=126)
n (%)
CategoryCharacteristics
92 (84.4)111 (88.1)HeroinDrugs injected in past 30 days
21 (19.3)26 (20.6)Prescription opioids
35 (32.1)36 (28.6)Cocaine
6 (5.5)1 (0.8)Methamphetamine
63 (57.8)67 (53.2)Less than dailyFrequency of drug injecting in past 30 days
46 (42.2)59 (46.8)Every day
36 (33.0)37 (29.6)NoHas shared needles, cottons, or cookers
73 (67.0)88 (70.4)Yes
70 (64.2)75 (60.5)NoHas had an opioid overdose
39 (35.8)49 (39.5)Yes
Using social networks to recruit participants allowed us to reach
a population that may have otherwise not been reached. In the
first phase of the study, prevention staff recruited 40 individuals
to participate who were existing clients of the syringe exchange
program. These participants referred 195 peers who were
determined to be eligible and were enrolled in the study. As
shown in Figure 3, linking participants via referral chains allows
visualization of 2 large networks and several smaller ones.
Figure 3. Network diagram of peer referral chains by hepatitis C virus testing history.
Discussion
Main Findings
The overarching goal of this pilot RCT was to determine if a
computerized, tailored intervention was feasible and acceptable
to implement in an syringe exchange program. Though its
potential impact in increasing HCV testing, overdose prevention,
and use of clean syringes and works will be reviewed after all
follow-up assessments and HCV testing follow-up data are
collected, the data collected to date demonstrate that the
approach is feasible overall. There was a high level of
willingness to participate, and many participants referred peers,
indicating acceptability of this type of intervention.
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Unanticipated Challenges
Throughout the initial period of enrollment and completion of
baseline assessments, the study staff encountered several
unanticipated challenges. Scheduling appointments for
enrollment and completion of study assessments proved to be
difficult; participants preferred to drop in at a time that was
convenient for them. Often, individuals forgot about their
appointments, did not have transportation to make it to their
scheduled appointment, and could not be reminded via phone
or text because they did not own a cell phone or have minutes.
Both study sites amended their procedures and became
accessible for drop-in appointments to accommodate the
difficulties faced by people who inject drugs in keeping
scheduled appointments.
The Hep-Net study was designed as a pragmatic intervention
trial rather than a highly controlled clinical trial, which would
have required more resources and been less generalizable to
other settings. Prevention staff had numerous responsibilities
that superseded the tasks they were asked to complete for the
research project, such as obtaining informed consent and
administering the computerized survey. Balancing these
competing demands required communication and an effective
partnership among the research team, the existing prevention
staff, and administrators of the syringe exchange program.
Within 2 months of enrolling the first participants, study site
staff began to identify the best time periods for survey visits
and how to best fit the intervention into routine prevention
services. When the study team and prevention staff determined
how to best achieve balance between research and service
activities, it became obvious that the most appropriate rate of
accruing new subjects would not allow recruitment of a sample
as large as originally planned. The target sample size was
modified after several months for this reason to the more
realistic goal of 120 subjects per group.
Computer literacy was another unanticipated challenge
experienced by study staff. Many participants had little
background using computers and struggled to understand how
to answer questions and advance the program. Although site
staff made themselves available for computer questions and
aided participants in computer fluidity, several participants took
over an hour to complete the survey rather than the anticipated
half hour.
Finally, Internet connectivity and a private space to screen and
deliver the survey were difficult barriers to overcome. Neither
syringe exchange program had readily available WiFi, so
Ethernet accessibility was imperative in collecting and
synchronizing survey data. Private spaces with Ethernet
accessibility were difficult to keep consistently vacant of other
prevention services, which made data collection more difficult.
Furthermore, a substantial number of study assessments were
completed via mobile syringe exchange outreach where no
Internet connectivity was available. The remote data collection
feature in the DatStat software package was used for these
surveys, which added a layer of complexity causing some
frustration among participants and staff.
The main limitation of this study is its lack of generalizability
to other cities and states and other local epidemics. While
Hep-Net may be feasibly used in the context of Wisconsin’s
opioid epidemic, it may not apply to other geographical areas
targeting the same population. This CTI used existing
preliminary data from a pilot study of over 500 Wisconsinites
to tailor the intervention content to a specific population.
Additionally, our sample was subject to selection bias because
individuals using a syringe exchange program tend to be a
healthier, higher-functioning subset of people who inject drugs.
Although the computerized approach to data collection was
designed for complete anonymity to reduce social desirability
bias, participants may have answered questions to please
researchers.
A major strength of this study is the use of well-established
syringe exchange programs as home to Hep-Net. The
community-based prevention specialists who implemented this
project are highly regarded among community members and
have built trust over years of service. Without their involvement,
acceptability of the intervention would likely have been much
lower.
Conclusion
If effective, Hep-Net has the possibility to facilitate a more
comprehensive approach to prevention and linkage to care
within syringe exchanges and other community-based programs.
Syringe exchange programs, while shown to be effective, are
already understaffed and lack resources. Hep-Net’s role is to
fill in the gaps presented by agency challenges to provide
behavioral care to a subset of a community that is substantially
underserved. To disseminate the intervention, busy syringe
exchange programs could present Hep-Net to clients or use the
Internet to reach rural or immobile populations. We hope the
results will lead to implementation of a CTI in community-based
settings. If the study hypotheses are confirmed, the proposed
solution can be tailored to specific cities and states and
disseminated to reduce the impact of hepatitis C among people
who inject drugs.
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Multimedia Appendix 1
Baseline questionnaire.
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Multimedia Appendix 2
Sample content screens from Hep-Net intervention.
[PDF File (Adobe PDF File), 769KB - resprot_v5i1e15_app2.pdf ]
Multimedia Appendix 3
Follow-up assessment.
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